NIH launches adaptive clinical trials of blood clotting treatments for COVID-19

(NIH/Office of the Director) The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the ACTIV initiative, these trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings -- those who have not been hospitalized, those currently hospitalized and those discharged after hospitalization for moderate to severe disease.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news